CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Enliven Therapeutics Insider Sold Shares Worth $263,373, According to a Recent SEC Filing

Neutral
AI Analysis

Summary

An insider at Enliven Therapeutics sold shares worth $263,373 according to a recent SEC filing. This is a routine disclosure with no material implications for the company.

Importance:1/10
Sentiment:
0.00
insider tradingSEC filingshare sale
Related Companies

Read the original article

Published by yahoo_finance on July 21, 2026 9:27 PM

Read Original